Systematic Review of Clinical and Economic Evidence for Primary Open-  Angle Glaucoma Therapy with Tafluprost vs Travoprost

Shoyusuf F. Shodmanov; Shakhnoza Z. Umarova; Zoya R. Usmanova

Authors

Shoyusuf F. Shodmanov
Shakhnoza Z. Umarova
Zoya R. Usmanova

Keywords:

primary open-angle glaucoma, systematic review, clinical efficacy, economic efficiency, PubMed

Abstract

Background: According to WHO, the number of patients with glaucoma in the world ranges from 60.5 to 105 million people, and the number of such patients is also predicted to increase to 80 million. Out of 28 million blind people in the world almost one in five lost their sight due to glaucoma. The aim of this research is to conduct a systematic review of the clinical and economic evidence for the treatment of primary open-angle glaucoma with Tafluprost vs Travoprost.

Downloads

How to Cite

Systematic Review of Clinical and Economic Evidence for Primary Open- Angle Glaucoma Therapy with Tafluprost vs Travoprost. (2022). Global Journal of Medical Research, 22(F3), 41-46. https://medicalresearchjournal.org/index.php/GJMR/article/view/2668

Download Citation

References

S Jalalov, Ch, D Jalalova, Kh, D Khoch (2012) The role of systematic review and meta-analysis in the evaluation of technologies in health care. (3), 10-15.

Iwasa Inoue, Tomita (2013) Effects of Tafluprost treatment for 3 years in patients with normal-tension glaucoma. 7, 1411-1416.

Kenji Inoue, Goji Tomita, Masato Wakakura, Mieko Masumoto (2012) Effects of BAK-free travoprost treatment for 3 years in patients with normal tension glaucoma. 6, 1315.

G Brown, M Brown (2019) Patient Preference-Based Comparative Effectiveness and Cost-Utility Analysis of the Prostamides for Open-Angle Glaucoma.

Nice (2017) Glaucoma: Diagnosis and management.

S Jalalov, Ch, D Jalalova, Kh, D Khoch (2014) Conceptualization of a model for medical technology assessment. (2), 18-20.

S Dzhalalov, D Dzhalalova, M Krahn, J Hoch (2020) Incremental vs. average cost-effectiveness ratio: which one is preferable in health technology assessment?. 41(3), 29.

David Rein (2006) The Economic Burden of Major Adult Visual Disorders in the United States. 124(12), 1754.

P Lichter (2001) Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. 108(11), 1943-1953.

Anders Heijl (2002) Reduction of Intraocular Pressure and Glaucoma Progression. 120(10), 1268.

Nice (2009) A new guideline to improve the diagnosis and management of chronic open angle glaucoma and ocular hypertension in the UK will be available from April 22. 577(1), 3-3.

Bryan Lee, Steven Kymes, Robert Nease, Walton Sumner, Carla Siegfried, Mae Gordon (2008) The Impact of Anchor Point on Utilities for 5 Common Ophthalmic Diseases. 115(5), 898-903.e4.

Ricardo Paletta Guedes, Vanessa Paletta Guedes, Sirley Freitas, Alfredo Chaoubah (2015) Does the type of treatment have an influence on utility values in a glaucoma population?. 1645.

Vivek Adwe, Khurshed Bharucha, Atul Hegade, Rahul Deshpande, Madan Deshpande, Vk Kalyani (2016) Evaluation of skills transfer in short-term phacoemulsification surgery training program by International Council of Ophthalmology -Ophthalmology Surgical Competency Assessment Rubrics (ICO-OSCAR) and assessment of efficacy of ICO-OSCAR for objective evaluation of skills transfer. 68(8), 1573.

A Liberati, D Altman, J Tetzlaff, C Mulrow, P Gotzsche, J Ioannidis, M Clarke, P Devereaux, J Kleijnen, D Moher (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. 339(jul21 1), b2700-b2700.